Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

CD101: A New Long-Acting Echinocandin

OCT 07, 2017 | CONTAGION® EDITORIAL STAFF


David Andes, MD, professor and chief of infectious disease at the University of Wisconsin, shares the half-life and dosing intervals for a new long-acting echinocandin.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x